Published 09/18/2024 5:09:00 p.m.

Roivant dermatology subsidiary to be acquired by Organon

Summary by biopharmadive.com

The deal hands Organon a psoriasis and eczema cream called Vtama, while Roivant will get more cash to fund its R&D plans.

0 Articles

All

Left

Center

Right

MedCity News

Organon Gets More Skin in the Game by Acquiring Roivant’s Dermatology Subsidiary

By acquiring Dermavant, Organon gets Vtama, a drug approved for treating plaque psoriasis. An FDA decision for the topical cream in atopic dermatitis is expected by the end of 2024. The post Organon Gets More Skin in the Game by Acquiring Roivant’s Dermatology Subsidiary appeared first on MedCity News.

09/18/2024 5:09:00 p.m.

Read Full Article

biopharmadive.com

Roivant dermatology subsidiary to be acquired by Organon

The deal hands Organon a psoriasis and eczema cream called Vtama, while Roivant will get more cash to fund its R&D plans.

09/18/2024 11:30:00 a.m.

Read Full Article

Dataemia

Organon Gets More Skin in the Game by Acquiring Roivant’s Dermatology Subsidiary

Organon is acquiring Dermavant, a company focused on dermatology, for up to $1.2 billion. Dermavant’s main asset is Vtama, a topical cream for plaque psoriasis that is also being reviewed for atopic dermatitis. Organon aims to expand the drug’s market and boost sales, although current projections have been lowered due to competition. Vtama’s mechanism of action could have applications in other skin disorders. Organon’s dermatology portfolio incl…

09/18/2024 8:09:07 p.m.

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center1Last Updated09/19/2024 8:06:59 a.m.Bias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Roivant dermatology subsidiary to be acquired by Organon

0 Articles

0 Articles

Organon Gets More Skin in the Game by Acquiring Roivant’s Dermatology Subsidiary

Organon Gets More Skin in the Game by Acquiring Roivant’s Dermatology Subsidiary

Roivant dermatology subsidiary to be acquired by Organon

Roivant dermatology subsidiary to be acquired by Organon

Organon Gets More Skin in the Game by Acquiring Roivant’s Dermatology Subsidiary

Organon Gets More Skin in the Game by Acquiring Roivant’s Dermatology Subsidiary

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics